Statement of Changes in Beneficial Ownership (4)
July 17 2013 - 5:56PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
ANIDO VICENTE JR
|
2. Issuer Name
and
Ticker or Trading Symbol
QLT INC/BC
[
QLTI
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
C/O QLT INC., 887 GREAT NORTHERN WAY, SUITE 101
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
7/15/2013
|
(Street)
VANCOUVER, A1 V5T 4T5
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Phantom Stock
(1)
|
(2)
|
7/15/2013
|
|
A
|
|
11000
|
|
(3)
|
(4)
|
Common Stock
|
11000
|
$0
|
11000
|
D
|
|
Restricted Stock Unit
|
(5)
|
7/15/2013
|
|
A
|
|
6000
|
|
(6)
|
(7)
|
Common Stock
|
6000
|
$0
|
6000
|
D
|
|
Stock option (right to buy)
|
$4.36
(8)
|
7/15/2013
|
|
A
|
|
12500
|
|
(9)
|
7/15/2023
|
Common Stock
|
12500
|
$0
|
12500
|
D
|
|
Explanation of Responses:
|
(
1)
|
Deferred stock units, which are payable only in cash.
|
(
2)
|
Each deferred stock unit is the economic equivalent of one share of common stock of the Issuer.
|
(
3)
|
The deferred stock units vest in thirty-six (36) successive and equal monthly installments beginning on the first day of the first month after the date of grant (or August 1, 2013), such that 100% of the deferred stock units will be fully vested on July 1, 2016.
|
(
4)
|
The deferred stock units have no fixed expiration date. Any vested deferred stock units are payable in cash upon the Reporting Person's departure from the Board of Directors of the Issuer, with any unvested deferred stock units expiring on such date.
|
(
5)
|
Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting.
|
(
6)
|
The restricted stock units vest in 3 successive and equal yearly installments on the date of each of the first three annual general meetings of the Issuer held after July 15, 2013.
|
(
7)
|
The restricted stock units have no fixed expiration date, but unvested units expire upon the Reporting Person's termination of service.
|
(
8)
|
Option exercise price reflects the conversion of Canadian dollars to U.S. dollars based on the exchange rate in effect as of the date of grant. The option exercise price is CAD $4.54 per share, which was the closing price of the Issuer's common stock on the Toronto Stock Exchange as of the date of grant.
|
(
9)
|
The options vest and become exercisable in thirty-six (36) successive and equal monthly installments beginning on the one-month anniversary of the date of grant (or August 15, 2013), such that 100% of the options will be fully vested on July 15, 2016.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
ANIDO VICENTE JR
C/O QLT INC.
887 GREAT NORTHERN WAY, SUITE 101
VANCOUVER, A1 V5T 4T5
|
X
|
|
|
|
Signatures
|
/s/ Dori Assaly, as attorney-in-fact
|
|
7/17/2013
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Novelion Therapeutics (NASDAQ:NVLN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Novelion Therapeutics (NASDAQ:NVLN)
Historical Stock Chart
From Sep 2023 to Sep 2024